36 related articles for article (PubMed ID: 19362968)
1. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract][Full Text] [Related]
2. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience.
Danesin N; Bonaldi L; Martines A; Nalio S; Bertorelle R; Compagno S; Marcato R; Manni S; Scarmozzino F; Pizzi M; Tos APD; Cellini A; Scapinello G; Visentin A; Trentin L; Piazza F
Ann Hematol; 2024 Apr; ():. PubMed ID: 38687347
[TBL] [Abstract][Full Text] [Related]
3. Current approach to Waldenström macroglobulinemia.
Kapoor P; Rajkumar SV
Blood Rev; 2023 Nov; 62():101129. PubMed ID: 37659912
[TBL] [Abstract][Full Text] [Related]
4. Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia.
Lim JH; Wang JQ; Webb F; Saxena K; Enosi Tuipulotu D; Pandey A; Man SM; Talaulikar D
iScience; 2022 Aug; 25(8):104856. PubMed ID: 35992066
[TBL] [Abstract][Full Text] [Related]
5. Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.
Wang J; Yan Y; Xiong W; Song G; Wang Y; Zhao J; Jia Y; Li C; Yu Z; Yu Y; Chen J; Jiao Y; Wang T; Lyu R; Li Q; Ma Y; Liu W; Zou D; An G; Sun Q; Wang H; Xiao Z; Wang J; Qiu L; Yi S
Blood Adv; 2022 Jul; 6(13):4049-4059. PubMed ID: 35537114
[TBL] [Abstract][Full Text] [Related]
6. Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance.
Drandi D; Decruyenaere P; Ferrante M; Offner F; Vandesompele J; Ferrero S
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454017
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of patients with multiple myeloma harboring 6q deletion].
Chen L; Sun CY; An BW; Yu JM; Zhao F; Zhang C; Hu Y
Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):642-645. PubMed ID: 34547869
[No Abstract] [Full Text] [Related]
8. Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion.
Sekiguchi N; Nomoto J; Nagata A; Kiyota M; Fukuda I; Yamada K; Takezako N; Kobayashi Y
Biomed Res Int; 2018; 2018():6728128. PubMed ID: 30402490
[TBL] [Abstract][Full Text] [Related]
9. Waldenstrom's Macroglobulinemia: An Update.
Mazzucchelli M; Frustaci AM; Deodato M; Cairoli R; Tedeschi A
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018004. PubMed ID: 29326801
[TBL] [Abstract][Full Text] [Related]
10. Impact of Glycosylation on Effector Functions of Therapeutic IgG.
Abès R; Teillaud JL
Pharmaceuticals (Basel); 2010 Jan; 3(1):146-157. PubMed ID: 27713246
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.
Nguyen-Khac F; Lambert J; Chapiro E; Grelier A; Mould S; Barin C; Daudignon A; Gachard N; Struski S; Henry C; Penther D; Mossafa H; Andrieux J; Eclache V; Bilhou-Nabera C; Luquet I; Terre C; Baranger L; Mugneret F; Chiesa J; Mozziconacci MJ; Callet-Bauchu E; Veronese L; Blons H; Owen R; Lejeune J; Chevret S; Merle-Beral H; Leblondon V; ; ;
Haematologica; 2013 Apr; 98(4):649-54. PubMed ID: 23065509
[TBL] [Abstract][Full Text] [Related]
12. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
13. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
Ocio EM; Schop RF; Gonzalez B; Van Wier SA; Hernandez-Rivas JM; Gutierrez NC; Garcia-Sanz R; Moro MJ; Aguilera C; Hernandez J; Xu R; Greipp PR; Dispenzieri A; Jalal SM; Lacy MQ; Gonzalez-Paz N; Gertz MA; San Miguel JF; Fonseca R
Br J Haematol; 2007 Jan; 136(1):80-6. PubMed ID: 17222197
[TBL] [Abstract][Full Text] [Related]
14. [Chromosomal abnormalities and Waldenström macroglobulinemia].
Berger R; Nguyen-Khac F
Pathol Biol (Paris); 2008 Sep; 56(6):400-6. PubMed ID: 18456427
[TBL] [Abstract][Full Text] [Related]
15. [Gene mutations connected to Waldenstöm macroglobulinemia].
Kutálková K; Sedlaříková L; Adam Z; Ševčíková S
Vnitr Lek; 2016 Jan; 62(1):40-3. PubMed ID: 26967235
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
Chang H; Qi C; Trieu Y; Jiang A; Young KH; Chesney A; Jani P; Wang C; Reece D; Chen C
Clin Lymphoma Myeloma; 2009 Mar; 9(1):36-8. PubMed ID: 19362968
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 6q deletion in Waldenstrom macroglobulinemia.
Chang H; Qi X; Xu W; Reader JC; Ning Y
Eur J Haematol; 2007 Sep; 79(3):244-7. PubMed ID: 17655703
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
